A review of common risks and pitfalls of incorporating artificial intelligence in medical devices and an overview of the regulatory framework.
A discussion with Peter Willemse about how configure, price, quote (CPQ) software can help medical device manufacturers deal with the nuances of everyday challenges and continue to drive revenue and increase profit margins.
Robust trends are expected to power the global digital diabetes management market.
Devices by themselves don’t improve outcomes. Better lifestyle integration is key to driving changes in patient compliance—embedding sensors into the sorts of devices people can use every day to increase opportunities for passive biometric capture and to facilitate therapeutics.
It’s time to take stock on what temporary measures need to be made permanent to grow as an industry.
Companies within the life sciences industry should rethink how they manage their data and documents.
Understanding the cost to service by product and by subcomponent will help you identify which service events are the most impactful to the bottom-line financials of the business.
Contract profitability requires real-time visibility into assets so manufacturers can make decisions proactively rather than reactively and maintain customer excellence.
Medtech businesses show tremendous potential for profitability and growth, triggering a sparked interest in investment.
Anyone can read the regulation. The challenge is in how to apply it to your company’s structure and product line.
